Search clinical trials for: QCC374

Total 3 results

Novartis Pharmaceuticals

Completed

A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374

Healthy Subjects

United Kingdom
Novartis Pharmaceuticals

Terminated

Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients

Pulmonary Arterial Hypertension

Germany, United Kingdom, United States
Novartis Pharmaceuticals

Terminated

Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients

Pulmonary Arterial Hypertension

Germany, Korea, Republic of, United Kingdom, United States

3

Subscribe